1. Home
  2. Analysis
  3. Halotestin
  4. Neupogen

Halotestin and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Halotestin (fluoxymesterone) and Neupogen (filgrastim). Common drug interactions include bone disorder among females.

The phase IV clinical study analyzes what interactions people have when they take Halotestin and Neupogen. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Halotestin?

Halotestin has active ingredients of fluoxymesterone. eHealthMe is studying from 92 Halotestin users. Check the latest studies of Halotestin.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

13 people who take Halotestin and Neupogen together, and have interactions are studied.

Halotestin and Neupogen drug interactions.

What are the common drug interactions of Halotestin and Neupogen, by gender? *:

female:

  1. Bone disorder
  2. Diarrhoea
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Back pain
  5. Cardiac failure congestive
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Decreased appetite
  8. Deformity (disfigurement)
  9. Dehydration (dryness resulting from the removal of water)
  10. Dermal cyst

male:

n/a

What are the common drug interactions of Halotestin and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Deformity (disfigurement)
  4. Dehydration (dryness resulting from the removal of water)
  5. Dermal cyst
  6. Diarrhoea
  7. Dysuria (painful or difficult urination)
  8. Emotional distress
  9. Fatigue (feeling of tiredness)
  10. Gait disturbance

What are the existing conditions these people have? *

  1. Bone Disorder: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Halotestin and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Halotestin and Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Halotestin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Halotestin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluoxymesterone and filgrastim (the active ingredients of Halotestin and Neupogen, respectively), and Halotestin and Neupogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.